AL-37807
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AL-37807, covering 2008-04-22 to 2008-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension [Phase 2]